Clinical Trial Update: A Research Study to See How Well Semaglutide Helps People Who Have a Body Weight Above the Healthy Weight Range [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating semaglutide for adults who are overweight or obese has completed. Sponsored by Novo Nordisk A/S.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Overweight

Drugs mentioned

• semaglutide (semaglutide)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Overweight, Obesity | Phase 3 | Status: COMPLETED